Durysta

About Durysta

Durysta is a sustained release medication that is painlessly inserted in the front part of the eye to help reduce intraocular pressure (IOP). It is used to manage open-angle glaucoma or in patients with elevated IOP due to ocular hypertension.

The implant slowly releases bimatoprost over several months. Some patients may have the benefits of reducing the number of daily glaucoma drops or not having to use daily drops to manage their IOP at all.

Durysta Crestview & Okaloosa County

Learn More About Durysta

Durysta is a tiny implant that slowly releases bimatoprost, a medication that increases the flow of aqueous fluid through the trabecular meshwork and the anterior chamber angle. By increasing how much fluid can flow through both areas, compensates for any blockage in the trabecular meshwork, and therefore helps to lower your IOP. This is a viable procedure for patients who do not respond to SLT.  It is also a great adjunctive therapy to their SLT if necessary.

Durysta will eventually dissolve in the eye and biodegrades into carbon dioxide and water. You do not need to worry about having it removed. The effects of the implant in lowering your IOP may last for several months for most patients. Some patients may enjoy the IOP lowering effects for up to 2 years.

A topical numbing medication is applied to the eye before inserting the Durysta implant. Dr. Alabata will inject the implant into the anterior chamber of the eye. This only takes a few seconds. You will be placed on an antibiotic drop for a few days and asked to stay upright for at least an hour following the procedure.

Your next outpatient follow-up appointment will be scheduled a few weeks afterward.

Clinical trials show that Durysta provides up to a 32% reduction in IOP. This is a safe alternative for those patients who have topical allergies to prostaglandin glaucoma medications since it is administered within the front part of the eye and not onto the surface of the eye. 

The effects of Durysta last for up to six months, and patients have fewer complaints or side effects compared to patients using traditional glaucoma eye drops. In some patients, the effects may last up to 2 years. 

Currently, the FDA has approved Durysta for a single treatment. However, there is an ongoing trial in the hopes of approving additional treatments for the future. 

As with any prostaglandin, Durysta still may have some effects such as iris color changes, exacerbations of pre-existing inflammation in the eye, or swelling of the retina.

Durysta cannot reverse damage to your optic nerve – it can only help prevent future progression from happening by lowering the eye pressure.

Schedule now by completing this form or calling us at (850) 331-3937 to discuss with Dr. Phil Alabata if you are a candidate for Durysta. A referral is not required.

Schedule a Consultation